Jupiter Life Line Hospitals Ltd. (JLHL) AI Stock Analysis

• Market Cap: ₹91.90B
• Dividend Yield: 0.14%
• Average Volume (3M): 1.01K
• Price to Earnings (P/E): 46.3
• Beta (1Y): 0.23
• Revenue Growth: 18.40%
• EPS Growth: 7.30%
• Country: IN
• Employees: 4,586
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 8.70
• Shares Outstanding: 65,566,025
• 10 Day Avg. Volume: 645
• 30 Day Avg. Volume: 1,006
• PEG Ratio: 14.64
• Price to Book (P/B): 7.55
• Price to Sales (P/S): 8.12
• P/FCF Ratio: -151.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 2,848.44
• Revenue Forecast (FY): ₹1.40T

• Rating: 67 Neutral
• Price Target: ₹1,627.00 ▲(5.47% Upside)

Jupiter Life Line Hospitals Ltd. has a strong financial foundation with consistent revenue and profit growth, which is the most significant factor. Technical analysis indicates a stable upward trend, but the high P/E ratio suggests overvaluation, impacting the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a robust business model and effective market strategies, ensuring long-term financial stability and expansion potential.

Operational Efficiency

Strong EBIT and EBITDA margins reflect effective cost management and operational efficiency, which are crucial for sustaining profitability and competitive advantage.

Market Position

Operating a network of multi-specialty hospitals positions the company well in the healthcare industry, offering diverse services and attracting a broad patient base.

Negative Factors

Cash Flow Management

Negative free cash flow growth suggests potential liquidity issues, which could limit the company's ability to invest in growth opportunities and manage financial obligations.

Free Cash Flow

The need for improved free cash flow highlights challenges in cash generation, which could impact the company's capacity to fund operations and strategic initiatives.

Leverage Management

Attention needed in cash flow management indicates potential strain on financial resources, affecting the company's ability to maintain a balanced leverage approach.

Jupiter Life Line Hospitals Ltd. Business Overview & Revenue Model

Company Description

Jupiter Life Line Hospitals Ltd. (JLHL) is a healthcare organization based in India that operates a network of multi-specialty hospitals, providing comprehensive medical services across various sectors including cardiology, oncology, neurology, orthopedics, and critical care. The company is dedicated to delivering high-quality healthcare solutions through advanced medical technology and expert clinical staff, focusing on patient-centric care and innovative treatment options.

How the Company Makes Money

Jupiter Life Line Hospitals Ltd. generates revenue primarily through patient admissions, which includes inpatient and outpatient services. The hospital charges fees for consultations, diagnostic tests, surgical procedures, and various therapeutic treatments. Additionally, JLHL may earn income from health insurance partnerships, where they receive reimbursements for services provided to insured patients. The company might also generate revenue from ancillary services, such as pharmacy, laboratory, and radiology services offered within their facilities. Strategic partnerships with insurance providers and corporate health programs contribute significantly to their earnings, as these collaborations often lead to increased patient volume and consistent revenue streams.

Jupiter Life Line Hospitals Ltd. Financial Statement Overview

Summary

Jupiter Life Line Hospitals Ltd. demonstrates strong financial health with consistent revenue and profit growth. The balance sheet is stable with manageable leverage, but cash flow management requires attention due to negative free cash flow growth.

Income Statement

Jupiter Life Line Hospitals Ltd. has shown consistent revenue growth over the years, with a notable increase in gross profit margins, indicating efficient cost management. The net profit margin has improved, reflecting enhanced profitability. EBIT and EBITDA margins are strong, showcasing operational efficiency.

Balance Sheet

The company has a healthy debt-to-equity ratio, indicating a balanced approach to leveraging. The return on equity is robust, suggesting effective use of shareholder funds. The equity ratio is stable, reflecting a solid financial foundation.

Cash Flow

While operating cash flow is strong, the negative free cash flow growth and ratio to net income indicate potential challenges in cash management. The operating cash flow to net income ratio is healthy, but improvements in free cash flow are needed.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	13.22B	12.62B	10.70B	8.93B	7.33B	4.86B
Gross Profit	10.74B	10.31B	8.55B	7.11B	4.07B	2.41B
EBITDA	3.44B	3.25B	2.61B	2.06B	1.50B	637.55M
Net Income	1.92B	1.93B	1.77B	729.05M	511.28M	-22.97M
Balance Sheet
Total Assets	0.00	19.05B	12.81B	9.86B	9.09B	7.89B
Cash, Cash Equivalents and Short-Term Investments	6.03B	6.03B	3.18B	1.36B	1.06B	266.46M
Total Debt	0.00	3.93B	623.41M	4.69B	4.95B	4.26B
Total Liabilities	-13.56B	5.49B	1.13B	6.22B	6.20B	5.42B
Stockholders Equity	13.56B	13.56B	11.69B	3.66B	2.94B	2.39B
Cash Flow
Free Cash Flow	0.00	-674.22M	292.26M	399.24M	452.40M	-1.18B
Operating Cash Flow	0.00	2.53B	1.15B	1.17B	1.37B	1.23B
Investing Cash Flow	0.00	-2.09B	-758.89M	-1.04B	-852.46M	-2.96B
Financing Cash Flow	0.00	3.01B	1.28B	175.00M	322.02M	1.84B

Jupiter Life Line Hospitals Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1542.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JLHL, the sentiment is Negative. The current price of 1542.6 is above the 20-day moving average (MA) of 1430.51, above the 50-day MA of 1484.12, and above the 200-day MA of 1477.13, indicating a bearish trend. The MACD of -24.63 indicates Positive momentum. The RSI at 41.87 is Neutral, neither overbought nor oversold. The STOCH value of 26.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JLHL.

Jupiter Life Line Hospitals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NH	71 Outperform	₹389.90B	45.91	―	0.23%	14.72%	8.37%
JLHL	67 Neutral	₹91.90B	46.28	―	0.14%	18.40%	7.30%
KIMS	65 Neutral	₹255.93B	76.17	―	―	25.74%	1.41%
MEDANTA	65 Neutral	₹314.23B	55.91	―	0.04%	15.78%	15.01%
ASTERDM	62 Neutral	₹310.12B	91.70	―	0.83%	-36.14%	-93.99%
FORTIS	61 Neutral	₹672.40B	66.31	―	0.11%	15.33%	54.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Jupiter Life Line Hospitals Ltd. Corporate Events

Jupiter Life Line Hospitals Announces Unaudited Financial Results for Q2 2025

Jupiter Life Line Hospitals Ltd. has announced the publication of its unaudited financial results for the quarter and half year ended September 30, 2025. The results, approved by the Board of Directors, have been published in Financial Express and Pudhari Newspaper Marathi and are available on the company’s website. This announcement reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its stakeholders by providing insights into its financial performance.

Jupiter Life Line Hospitals Announces Earnings Call for Q2 & H1 FY26

Jupiter Life Line Hospitals Ltd. has announced an upcoming earnings conference call scheduled for November 10, 2025, to discuss its operational and financial performance for the second quarter and first half of fiscal year 2026. This call is an opportunity for investors and analysts to gain insights into the company’s financial health and strategic direction, potentially impacting stakeholder perceptions and market positioning.

Jupiter Life Line Clarifies Expansion Plans in Maharashtra

Jupiter Life Line Hospitals Ltd. has clarified that recent news about its Rs 1,400-crore expansion in Maharashtra, aimed at doubling its capacity by 2029, is based on information already available in the public domain. The company emphasized that there are no new developments or undisclosed negotiations, and it remains committed to transparent and timely disclosures in line with regulatory requirements.